Global Vascular Closing Device Market Growth 2023-2029

Global Vascular Closing Device Market Growth 2023-2029

Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.

Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.

Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.

LPI (LP Information)' newest research report, the “Vascular Closing Device Industry Forecast” looks at past sales and reviews total world Vascular Closing Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Vascular Closing Device sales for 2023 through 2029. With Vascular Closing Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Closing Device industry.

This Insight Report provides a comprehensive analysis of the global Vascular Closing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Closing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vascular Closing Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Closing Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Closing Device.

The global Vascular Closing Device market size is projected to grow from US$ 1014.3 million in 2022 to US$ 1248.2 million in 2029; it is expected to grow at a CAGR of 1248.2 from 2023 to 2029.

Global core vascular closure devices manufacturers include Abbott Laboratories, Terumo Corporation etc.The top 1 company hold a share about 50%. North America is the largest market, with a share about 45%, followed by Asia Pacific and Europe with the share about 25% and 17%.In terms of product, 8F is the largest segment, with a share over 20%. And in terms of application, the largest application is interventional procedures, followed by angiography surgery.

This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Closing Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Disposable
Reusable

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Morris Innovative
Transluminal Technologies
Vivasure Medical Ltd
Cardinal Health

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vascular Closing Device market?

What factors are driving Vascular Closing Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vascular Closing Device market opportunities vary by end market size?

How does Vascular Closing Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.